Brand Name(s): Prinivil; Zestril
CAS nº: 83915-83-7
(Lyse in' oh pril)
About Lisinopril
This new site is dedicated exclusively to lisinopril.
It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.
Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about lisinopril, as well as take part in our open discussion forum by sharing your own knowledge and experiences with people who are using this medication.
This unique site will also offer you inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total lisinopril experience!
Why is this medication prescribed?
Lisinopril is in a class of drugs called angiotensin-converting-enzyme (ACE) inhibitors.
This medicine is used to lower blood pressure, to treat congestive heart failure and to improve the survival rate after a heart attack. It decreases certain chemicals that tighten the blood vessels, (in other words lisinopril dilates the blood vessels) so blood flows more smoothly and the heart can pump blood more efficiently.
Interestingly, lisinopril and other ACE inhibitors were developed from the venom of a poisonous Brazilian snake.
This medication was first developed by Merck & Co., and is marketed worldwide by Merck with the brand name Prinivil® and by AstraZeneca with the brand name Zestril®. In Australia it is marketed by AlphaPharm with the brand name Lisodur®. In most countries generics are available.
Latest News
Focus more towards CRAMS biz: Lupin
Speaking to CNBC-TV18, Kamal K Sharma, MD, Lupin, said international revenues account for 60% of...
[more]Diuretics Trump Newer Drugs for Hypertension in Metabolic Syndrome
Diuretics proved equal or superior to newer, more costly drugs in preventing adverse cardiovascular...
[more]Thiazides first-choice antihypertensive even for patients with metabolic syndrome
New findings from ALLHAT fail to support the preference for calcium blockers, alpha blockers, or...
[more]Pharmacogenetic Association of the NPPA T2238C Genetic Variant With Cardiovascular Disease Outcomes in Patients With Hypertension
Context: The NPPA gene codes for the precursor of atrial natriuretic polypeptide, suggesting that...
[more]Warm water no better at killing germs than cold
Q: I was interested in the column about a person who developed a cough while taking lisinopril. I...
[more]Advertisement
Join Extrapounds.com and enjoy healthy weight loss!